急性缺血性卒中早期血浆miRNAs水平与房颤发生间的关系

doi:10.16150/j.1671-2870.2017.01.019

诊断学理论与实践 ›› 2017, Vol. 16 ›› Issue (01): 98-103.doi: 10.16150/j.1671-2870.2017.01.019

急性缺血性卒中早期血浆miRNAs水平与房颤发生间的关系

胡荣郭^a, 庞德芳^b, 黄澍^a, 沈振坤^a, 陈玮^c, 杨育伟^d, 来小音^a, 朱玮^a, 吴菲菲^a, 计海峰^a, 吴大玉^a, 江梅^a, 孙家兰^a, 李龙宣^a

上海市浦东新区公利医院 a.神经科,b.公共关系部,c.放射科,d.介入科,上海 200135

收稿日期:2017-01-20 出版日期:2017-02-25 发布日期:2022-06-20
通讯作者: 李龙宣 E-mail: Longxuanlee30@aliyun.com
基金资助:
国家自然科学基金面上项目（81571203）; 上海市自然科学基金项目（15ZR1437200）; 上海市浦东新区科技发展基金（PKJ2014-Y21）; 上海市浦东新区卫生系统领先人才培养计划（PWR12014-05）; 上海市浦东新区卫生系统重点学科建设资助（PWZx2014-08）; 上海市医学重点专科建设计划项目（ZK2015B16）

Correlation of plasma miRNAs levels with atrial fibrillation in patients with acute cerebral infarction in early stage

HU Rongguo^a, PANG Defang^b, HUANG Shu^a, SHEN Zhenkun^a, CHEN Wei^c, YANG Yuwei^d, LAI Xiaoyin^a, ZHU Wei^a, WU Feifei^a, JI Haifeng^a, WU Dayu^a, JIANG Mei^a, SUN Jialan^a, LI Longxuan^a

a. Department of Neurology, b. Department of Public Relations, c. Department of Radiology, d. Department of Interventional Radiology, Gongli Hospital, Pudong New Area, Shanghai 200135, China

Received:2017-01-20 Online:2017-02-25 Published:2022-06-20

摘要/Abstract

摘要： 目的：探讨急性缺血性卒中早期患者外周血浆中的一组miRNAs水平与心房颤动（房颤）发生间的关系及临床意义。方法：选择2014年1月至2016年12月在我院住院的急性缺血性卒中患者,根据其是否伴发房颤分为房颤组（70例）与非房颤组（631例）,另选择65名健康体检者作为对照组。比较各组间的一般临床资料及缺血性卒中患者早期血浆中一组miRNAs分子的变化;观察伴不同类型房颤与非房颤缺血性卒中患者血浆中的miRNAs差异表达;并进一步用Logistic回归分析miRNAs水平与缺血性卒中患者伴房颤发生间的关系。结果：血浆中miR-328、miR-29b和miR-150水平在房颤组、非房颤组与对照组间存在差异表达（P<0.05;P<0.01）;不同于miR-328和miR-150,miR-29b在伴阵发性房颤的缺血性卒中患者血浆中的水平显著低于非房颤组缺血性卒中患者及对照组（P<0.01）。Logistic回归分析结果显示,血浆中的miR-328、miR-29b及miR-150水平与急性缺血性卒中患者伴发房颤密切相关;miR-29b水平与急性缺血性卒中患者伴发阵发性房颤密切相关。结论：急性缺血性卒中早期血浆中一组特异性miRNAs分子,特别是miR-29b有望作为急性缺血性卒中患者是否合并房颤的生物学预警指标。

关键词: 急性缺血性卒中, 心房颤动, 微小RNA

Abstract: Objective: To investigate the correlation between the plasma miRNAs levels and atrial fibrillation (AF) in patients with acute cerebral infarction in early stage. Methods: Seven hundred and one patients with acute cerebral infraction addmitted in Gongli Hospital during Jan. 2014 to Nov. 2016 were enrolled, and patients were divided into two groups: group with AF(70 cases) and group without AF (631 cases), and 65 healthy cases were served as controls. Clinical data and miRNAs levels between the 3 groups were analyzed, and miRNAs levels were also compared between paroxysmal and persistent AF. Multivariate regression analysis was used to determine the contribution of plasma miRNAs variables to the presence of atrial fibrillation in patients with cerebral infarction in early stage. Results: Plasma levels of miR-328, miR-29b and miR-150 differed significantly between group with AF, group without AF and control group (P<0.05, P<0.01). Different from miR-328 and miR-150, plasma level of miR-29b in cerebral infarction patients with paroxysmal AF was significantly lower than those in group without AF and controls (P<0.01). Logistic regression analysis showed that the specific miRNAs, miR-328, miR-29b and miR-150 were significantly associated with AF and miR-29b was significantly related to paroxysmal AF in patients with acute cerebral infarction. Conclusions: Levels of some specific plasma miRNAs, especially the miR-29b level might be used as predictor for the existing of AF in patients with acute cerebral infraction in early stage.

Key words: Acute cerebral infarction, Atrial fibrillation, MicroRNAs

中图分类号:

R743.33

胡荣郭, 庞德芳, 黄澍, 沈振坤, 陈玮, 杨育伟, 来小音, 朱玮, 吴菲菲, 计海峰, 吴大玉, 江梅, 孙家兰, 李龙宣. 急性缺血性卒中早期血浆miRNAs水平与房颤发生间的关系[J]. 诊断学理论与实践, 2017, 16(01): 98-103.

HU Rongguo, PANG Defang, HUANG Shu, SHEN Zhenkun, CHEN Wei, YANG Yuwei, LAI Xiaoyin, ZHU Wei, WU Feifei, JI Haifeng, WU Dayu, JIANG Mei, SUN Jialan, LI Longxuan. Correlation of plasma miRNAs levels with atrial fibrillation in patients with acute cerebral infarction in early stage[J]. Journal of Diagnostics Concepts & Practice, 2017, 16(01): 98-103.

参考文献

[1] Murakoshi N, Aonuma K.Epidemiology of arrhythmias and sudden cardiac death in Asia[J]. Circ J,2013,77(10):2419-2431.
[2] Tse HF, Wang YJ, Ahmed Ai-Abdullah M, et al. Stroke prevention in atrial fibrillation--an Asian stroke perspective[J]. Heart Rhythm,2013,10(7):1082-1088.
[3] Hohnloser SH, Pajitnev D, Pogue J, et al.Incidence of stroke in paroxysmal versus sustained atrial fibrillation in patients taking oral anticoagulation or combined antiplatelet therapy: an ACTIVE W Substudy[J]. J Am Coll Cardiol,2007,50(22):2156-2161.
[4] Flint AC, Tayal AH.The search for paroxysmal atrial fi-brillation in cryptogenic stroke: leave no stone unturned[J]. Neurology,2013,80(17):1542-1543.
[5] King A.Atrial fibrillation: Could subclinical AF be a missing link in the etiology of cryptogenic stroke?[J]. Nat Rev Cardiol,2012,9(3):126.
[6] Manina G, Agnelli G, Becattini C, et al.96 hours ECG monitoring for patients with ischemic cryptogenic stroke or transient ischaemic attack[J]. Intern Emerg Med,2014, 9(1):65-67.
[7] Sanna T, Diener HC, Passman RS, et al.Cryptogenic stroke and underlying atrial fibrillation[J]. N Engl J Med,2014,370(26):2478-2486.
[8] Moubarak G, Tamazyan R, Garcon P, et al.Detection of occult atrial fibrillation by pacemaker interrogation in cryptogenic stroke[J]. J Interv Card Electrophysiol,2014, 39(3):261-265.
[9] Baibars M, Kanjwal K, Marine JE.AF detected on implanted cardiac implantable electronic devices: is there a threshold for thromboembolic risk?[J]. Curr Treat Options Cardiovasc Med,2014,16(3):289.
[10] Wang X, Qiu CG, Huang ZW, et al.The expression and clinical implication of plasma miR-328 in patients with atrial fibrillation[J]. Zhonghua Xin Xue Guan Bing Za Zhi,2013,41(2):126-129.
[11] Dawson K, Wakili R, Ordög B, et al. MicroRNA29: a mechanistic contributor and potential biomarker in atrial fibrillation[J]. Circulation,2013,127(14):1466-1475,1475e1-1475e28.
[12] Liu Z, Zhou C, Liu Y, et al.The expression levels of plasma micoRNAs in atrial fibrillation patients[J]. PLoS One,2012,7(9):e44906.
[13] 彭彬, 吴大玉, 孙家兰, 等. 急性脑梗死早期血中miRNAs水平与脑侧支循环建立的关系[J]. 中风与神经疾病杂志,2016,33(2):100-103.
[14] Lu Y, Zhang Y, Wang N, et al.MicroRNA-328 contributes to adverse electrical remodeling in atrial fibrillation[J]. Circulation,2010,122(23):2378-2387.
[15] McManus DD, Lin H, Tanriverdi K, et al. Relations between circulating microRNAs and atrial fibrillation: data from the Framingham Offspring Study[J]. Heart Rhythm,2014,11(4):663-669.
[16] Small EM, Olson EN.Pervasive roles of microRNAs in cardiovascular biology[J]. Nature,2011,469(7330):336-342.
[17] de Boer HC, van Solingen C, Prins J, et al. Aspirin treatment hampers the use of plasma microRNA-126 as a biomarker for the progression of vascular disease[J]. Eur Heart J,2013,34(44):3451-3457.
[18] Wang Y, Huang J, Ma Y, et al.MicroRNA-29b is a thera-peutic target in cerebral ischemia associated with aquaporin 4[J]. J Cereb Blood Flow Metab,2015,35(12):1977-1984.
[19] Khanna S, Rink C, Ghoorkhanian R, et al.Loss of miR-29b following acute ischemic stroke contributes to neural cell death and infarct size[J]. J Cereb Blood Flow Metab,2013,33(8):1197-1206.
[20] Llombart V, Garcia-Berrocoso T, Bustamante A, et al.Cardioembolic stroke diagnosis using blood biomarkers[J]. Curr Cardiol Rev,2013,9(4):340-352.
[21] McManus DD, Tanriverdi K, Lin H, et al. Plasma microRNAs are associated with atrial fibrillation and change after catheter ablation(the miRhythm study)[J]. Heart Rhythm,2015,12(1):3-10.

急性缺血性卒中早期血浆miRNAs水平与房颤发生间的关系

Correlation of plasma miRNAs levels with atrial fibrillation in patients with acute cerebral infarction in early stage

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	刘彤, 王鑫. 心房颤动预后不良风险的评估策略[J]. 诊断学理论与实践, 2020, 19(06): 555-558.
[2]	张星明, 顾文莉. 微小RNA-337-3p在口腔鳞状细胞癌中的表达及临床意义[J]. 诊断学理论与实践, 2020, 19(05): 510-515.
[3]	罗晓颖, 许燕, 张建盛, 吴立群, 戚文航. N端脑钠肽前体预测首次急性心肌梗死后新发心房颤动的价值研究[J]. 诊断学理论与实践, 2020, 19(03): 303-307.
[4]	王晨琛, 杨文波, 华玮, 陈晔芬, 苏秀秀, 龚俊世, 方跃华. 左心耳解剖形态、功能与非瓣膜性心房颤动患者脑卒中发生风险的相关性研究[J]. 诊断学理论与实践, 2020, 19(02): 151-156.
[5]	李莉, 卞炳贤, 张良, 沈立松. 尿液多种microRNA检测方法的建立及其在膀胱癌诊断中的应用研究[J]. 诊断学理论与实践, 2017, 16(01): 93-97.
[6]	黄红漫, 查爽英, 刘新兵, 柏晓松, 冯六六. 超高龄心房颤动患者华法林抗凝过程中心血管不良事件的观察[J]. 诊断学理论与实践, 2016, 15(05): 513-516.
[7]	张海晨, 陈佳, 宋云霄, 蔡海斌, 丰睿捷, 倪培华, 刘湘帆,. 肝癌高表达转录本调控microRNA613促进肝癌细胞增殖的机制研究[J]. 诊断学理论与实践, 2015, 14(06): 533-538.
[8]	刘兴鹏, 廖文凯,. 心房颤动的驱动机制认识[J]. 诊断学理论与实践, 2015, 14(03): 197-200.
[9]	吴立群,. 心房颤动的现代诊断及导管消融治疗进展认识[J]. 诊断学理论与实践, 2015, 14(03): 201-203.
[10]	陈松文, 刘少稳,. 心房颤动患者应用新型口服抗凝药物的指南解读[J]. 诊断学理论与实践, 2015, 14(03): 204-207.
[11]	吴杰,. 自主神经异常与心房颤动[J]. 诊断学理论与实践, 2015, 14(03): 208-210.
[12]	徐北惠, 梁璆荔, 倪培华,. 乳腺癌细胞自噬与相关miRNA研究进展[J]. 诊断学理论与实践, 2014, 13(04): 429-432.
[13]	邹彦芳, 张文, 陈楠,. MicroRNA在急性肾损伤中的研究进展[J]. 诊断学理论与实践, 2013, 12(04): 478-482.
[14]	刘佳, 杨新春, 蔡军,. 高血压相关的微小RNA研究进展[J]. 诊断学理论与实践, 2012, 11(06): 627-629.
[15]	陈颖, 宁光,. 循环微小RNA及其临床应用的研究进展[J]. 诊断学理论与实践, 2012, 11(02): 201-204.